期刊文献+

磁性纳米颗粒作为载体在基因转染中的研究进展 被引量:1

Progress of Magnetic Nanoparticles as Gene Vector
下载PDF
导出
摘要 磁性纳米颗粒具有很强的结合、浓缩与保护DNA的作用,具有超顺磁性、较高的安全性和低的免疫原性,可以结合大片段DNA,在外加磁场的作用下可实现安全、高效的基因靶向性运输,提高外源基因的转染效率。由于磁性纳米颗粒的独特性质,使得其作为非病毒载体在基因治疗中的应用进展迅速。我们简要介绍磁性纳米材料的特点、种类及结构,磁性纳米基因载体的特点,以及磁性纳米颗粒作为载体在基因转染中的应用情况。 Magnetic nanoparticles had stronger ability to bind DNA. DNA and magnetic nanoparticles can form close and tight complex structure. The magnetic nanoparticles can protect DNA against the digestion of nuclease, which have some characteristics such as combination with big fragment DNA, low immunogenic, good biocompatibil-ity and targeted gene delivery by application of a magnetic field. Magnetic nanoparticles can improve transfection efficiency, achieve safe and efficient transport of gene. As a nonviral gene vector, the application of magnetic nanoparticles in gene therapy developed rapidly. In this article, we discussed the characteristics, varieties and struc-ture of magnetic nanoparticles, characteristics of magnetic nanoparticles as gene vector, the progress on magnetic nanoparticles as gene vector.
作者 卢艳敏
出处 《生物技术通讯》 CAS 2013年第5期736-740,共5页 Letters in Biotechnology
关键词 磁性纳米颗粒 基因载体 转染 基因治疗 magnetic nanoparticles gene vectors transfection gene therapy
  • 相关文献

参考文献51

  • 1Wu Q, Moyana T, Xiang J. Cancer gene therapy by adenovi- rus-mediated gene transfer[J]. Curt Gene Ther, 2001,1:101- 122. 被引量:1
  • 2Yang Y, Xu Z, Jiang J, et al. Poly(imidazole/DMAEA) phosp- hazene/DNA self-assembled nanoparticles for gene delivery: Synthesis and in vitro transfection[J]. J Control Rel, 2008,127 (3):273-279. 被引量:1
  • 3Fischer Y H, Miletic H, Giroglou T, et al. A retroviral pack- aging cell line for pseudotype vectors based on glioma-infil- trating progenitqrsis[J]. J Gene Med, 2007,9(5):335-344. 被引量:1
  • 4Piao Y, Jiang H, Alemany R, et al. Oneolytic adenovirus re- targeted to Delta-EGFR induces selective antigloma activity [J]. Cancer Gene Thor, 2009,16(3):256-265. 被引量:1
  • 5Kock N, Kasmieh R, Weissleder R, et al. Tumor therapy me- diated by lentiviral expression of shBcl-2 and S-TRAIL[J]. Neoplasia, 2007,9(5):435-442. 被引量:1
  • 6Marumoto T, Tashiro A, Friedmann-Morvinski D, et al. Devel- opment of a novel mouse glioma model using lentiviral vectors [J]. Nat Med, 2009,15(1):110-116. 被引量:1
  • 7Zhao P, Wang C, Fu Z, et al. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma ceils in a telomere length-independent manner[J]. Int J Oncol, 2007,31 (2):361-368. 被引量:1
  • 8Markert J M, Parker J N, Buchsbaum D J, et al. Oncolytic HSV-1 for the treatment of brain tumours[J]. Herpes, 2006,13 (3):66-71. 被引量:1
  • 9Moralli D, Simpson K M, Wade-Martins R, et al. A novel hu- man artificial chromosome gene expression system using her-pes simplex virus type1 vectors[J]. EMBO Rep, 2006,7(9):911- 918. 被引量:1
  • 10Luo D, Sahzman W M. Synethetic DNA delivery systems[J]. Nat Biotechnol, 2000,18:33-37. 被引量:1

二级参考文献32

共引文献58

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部